[
    {
        "text": "There could be a new treatment in the fight against COVID.",
        "startTime": 466,
        "endTime": 3706,
        "slowStartTime": 849,
        "slowEndTime": 5784
    },
    {
        "text": "Regeneron said it's pursuing US approval...",
        "startTime": 4103,
        "endTime": 6559,
        "slowStartTime": 6304,
        "slowEndTime": 10064
    },
    {
        "text": "...for its COVID-19 antibody cocktail as a preventative treatment...",
        "startTime": 6695,
        "endTime": 10907,
        "slowStartTime": 10192,
        "slowEndTime": 16585
    },
    {
        "text": "...after it helped cut the risk of symptomatic infections in households...",
        "startTime": 11264,
        "endTime": 14944,
        "slowStartTime": 17046,
        "slowEndTime": 22641
    },
    {
        "text": "...where someone else is ill.",
        "startTime": 15181,
        "endTime": 16803,
        "slowStartTime": 22922,
        "slowEndTime": 25429
    },
    {
        "text": "According to trial data released by the company,...",
        "startTime": 16980,
        "endTime": 19579,
        "slowStartTime": 25620,
        "slowEndTime": 29594
    },
    {
        "text": "...the drug protected household contacts exposed to COVID...",
        "startTime": 19879,
        "endTime": 23256,
        "slowStartTime": 29968,
        "slowEndTime": 35109
    },
    {
        "text": "...from ever developing symptoms in the majority of the cases...",
        "startTime": 23551,
        "endTime": 26630,
        "slowStartTime": 35477,
        "slowEndTime": 40170
    },
    {
        "text": "...with 72 percent protection against symptomatic infections in the first week...",
        "startTime": 26985,
        "endTime": 31727,
        "slowStartTime": 40627,
        "slowEndTime": 47816
    },
    {
        "text": "...and 93 percent after that.",
        "startTime": 32088,
        "endTime": 34412,
        "slowStartTime": 48282,
        "slowEndTime": 51843
    },
    {
        "text": "Regeneron has enlisted Switzerland's Roche...",
        "startTime": 34631,
        "endTime": 37305,
        "slowStartTime": 52096,
        "slowEndTime": 56183
    },
    {
        "text": "...and its massive biotech facility in south San Francisco...",
        "startTime": 37378,
        "endTime": 41169,
        "slowStartTime": 56217,
        "slowEndTime": 61978
    },
    {
        "text": "...to make around two million doses annually.",
        "startTime": 41293,
        "endTime": 43968,
        "slowStartTime": 62090,
        "slowEndTime": 66177
    },
    {
        "text": "The cocktail already has emergency US approval...",
        "startTime": 44224,
        "endTime": 47213,
        "slowStartTime": 66486,
        "slowEndTime": 71045
    },
    {
        "text": "...for patients with mild to moderate COVID...",
        "startTime": 47315,
        "endTime": 49680,
        "slowStartTime": 71123,
        "slowEndTime": 74745
    },
    {
        "text": "...and the companies are hoping the latest trials...",
        "startTime": 50056,
        "endTime": 52183,
        "slowStartTime": 75234,
        "slowEndTime": 78500
    },
    {
        "text": "...convince regulators to expand deployment.",
        "startTime": 52325,
        "endTime": 55397,
        "slowStartTime": 78638,
        "slowEndTime": 83321
    },
    {
        "text": "Medical experts say it could be useful...",
        "startTime": 55541,
        "endTime": 57902,
        "slowStartTime": 83461,
        "slowEndTime": 87078
    },
    {
        "text": "...to control outbreaks in high-risk settings...",
        "startTime": 57989,
        "endTime": 60236,
        "slowStartTime": 87134,
        "slowEndTime": 90579
    },
    {
        "text": "...where people haven't been vaccinated.",
        "startTime": 60563,
        "endTime": 63006,
        "slowStartTime": 90994,
        "slowEndTime": 94734
    }
]